%0 Journal Article
%T Acquired tracheomalacia due to SARS-CoV-2 pneumonia.
%A Espejo D
%A Zapata M
%A Omari S
%A Muñoz X
%A Cruz MJ
%A  
%J Clin Respir J
%V 18
%N 1
%D 2024 Jan
%M 38666787
%F 1.761
%R 10.1111/crj.13719
%X <B>BACKGROUND: </B>Several studies mentioned parenchymal findings after SARS-CoV-2 pneumonia, but few studies have mentioned alterations in the airways. The aim of this study was to estimate the prevalence of tracheomalacia and to analyse the clinical characteristics in a cohort of patients with SARS-CoV-2.<BR><B>METHODS: </B>The study population consisted of all patients with SARS-CoV-2 admitted a hospital serving a population of 500 000 inhabitants. Patients were visited between 2 and 6 months after hospital discharge. In this visit, all patients were subjected to an exhaustive clinical questionnaire and underwent clinical examination, pulmonary function tests and chest CT.<BR><B>RESULTS: </B>From February 2020 to August 2021, 1920 patients were included in the cohort and tracheomalacia was observed in 15 (0.8%) on expiratory HRCT imaging. All patients with tracheomalacia also presented ground glass opacities in the CT scan and 12 patients had airway sequelae.<BR><B>CONCLUSIONS: </B>Tracheomalacia is an exceptional sequela of SARS-CoV-2 survivors.